
Overview
Background
Michael has over 30 years’ experience in clinical medicine (infectious diseases & paediatrics) and clinical laboratory microbiology with a particular interest in the epidemiology of vaccine preventable diseases and the diagnosis of infectious diseases in hospital, public health and industry settings. He recently took up the inaugural Director of Research at The Prince Charles Hospital in Brisbane.
He is a past Principal Medical Officer and Director of CoVID-19 Pharmacovigilance at the Therapeutic Goods Administration, Department of Health & Ageing, Australian Government (2021-2022), Director of Scientific Affairs & Public Health for GSK Vaccines in the Greater China Intercontinental region based in Singapore (2014-2020) and Director of Infectious Diseases at the Royal Children’s Hospital-Brisbane and a practising Clinical Microbiologist at the Royal Brisbane & Women’s Hospitals (2000-2014). Michael is a past full member of the Australian Technical Advisory Group for Immunisation from 2007 to 2013.
Prof. Nissen has 223 peer-reviewed medical publications and book chapters, a h- index of 64 with 13,321 citations of his work to date. His research interests include the epidemiology and prevention of vaccine preventable diseases and the rapid molecular diagnostic techniques of infectious diseases.
Availability
- Dr Michael Nissen is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
- Royal Australasian College of Physicians, Royal Australasian College of Physicians
- Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia
Research impacts
Founder & Co-Lead of Queensland Paediatric Infectious Diseases Laboratory & Associate Professor, University of Queensland Australia: 2003-2014
Research laboratory dedicated to viral discovery, translational adaption of molecular techniques for the diagnosis of infectious and rapid molecular diagnosis of respiratory viruses. Co-discoverer of WU virus. Lead approximately 40 Phase I-IV vaccine trials in attached clinical trials unit including meningococcal and staphylococcal candidates. Established experience in the maintenance and utility of large microbiology (virus and bacteria) and serum biobanks that lead to significant viral discoveries and clinical translation.
Co-discoverer of WU Virus: 2007
Gaynor AM, MD Nissen, DM Whiley, IM Mackay, SB Lambert, G Wu, DC Brennan, GA Storch, TP Sloots, D Wang (2007). Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathogens May 4; 3(5):e64 doi:10.1371/journal.ppat.0030064 (Citations: 846).
Director of Infectious Diseases, Royal Children’s Hospital-Brisbane, QLD AUSTRALIA: 2003-2014
Foundation and Inaugural Director of Clinical Infectious Diseases (Infection Management Prevention Service-IMPS) and Pre-Eminent Staff Specialist at largest children’s hospital in Queensland and State-based Children’s Health Service (CHS). Established Antimicrobial Stewardship (AMS) Committee at CHS and developed the “AntibioCard.” Also acted as Chair of the Infection Control Committee during this period and served as paediatric representative on State Health Medicines Advisory Committee (2000-2014).
Works
Search Professor Michael Nissen’s works on UQ eSpace
1984
Other Outputs
Wuchereria bancrofti infection in a rural population, Sorsogon Province, Republic of the Philippines
Nissen, Michael (1984). Wuchereria bancrofti infection in a rural population, Sorsogon Province, Republic of the Philippines. Bachelor's Thesis, School of Molecular and Microbial Sciences, The University of Queensland. doi: 10.14264/734803
Funding
Supervision
Availability
- Dr Michael Nissen is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2013
Doctor Philosophy
Molecular Characterisation and Detection of Gonococcal Antimicrobial Resistance.
Principal Advisor
Other advisors: Associate Professor David Whiley
-
2010
Doctor Philosophy
Clinical and virological characteristics of human metapneumovirus
Principal Advisor
-
2005
Doctor Philosophy
RESPIRATORY DISEASES IN PATIENTS WITH CYSTIC FIBROSIS: ROLE AND PATHOGENESIS OF PSEUDOMONAS AERUGINOSA INFECTION
Principal Advisor
-
2003
Doctor Philosophy
REAL-TIME DETECTION, DIFFERENTIATION AND QUANTITATION OF CLINICALLY RELEVANT VIRUSES
Principal Advisor
-
2010
Doctor Philosophy
Characterisation of Newly Discovered Human Polyomaviruses WU and KI
Joint Principal Advisor
-
2016
Doctor Philosophy
A nationwide study of Neisseria gonorrhoeae antimicrobial resistance; towards molecular AMR surveillance
Associate Advisor
Other advisors: Associate Professor David Whiley
-
2015
Doctor Philosophy
Epidemiology, Diagnosis and Prevention of Q fever in Queensland.
Associate Advisor
-
2015
Doctor Philosophy
Characterising the Pathogenesis and Biology of Newly Described Human Polyomaviruses
Associate Advisor
Other advisors: Associate Professor David Whiley, Dr Seweryn Bialasiewicz
-
2013
Doctor Philosophy
Detection, Identification and Genotyping of Pseudomonas aeruginosa strains isolated from environmental and clinical samples.
Associate Advisor
Other advisors: Associate Professor David Whiley
-
-
2008
Doctor Philosophy
Factors Affecting Nucleic Acid Amplification Tests for Neisseria Gonorrhoeae
Associate Advisor
Media
Enquiries
For media enquiries about Dr Michael Nissen's areas of expertise, story ideas and help finding experts, contact our Media team: